Updated Jul 16, 2026
Prange Karen has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $86K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | OM | Outset Medical, Inc. | A — Grant or award | 10.7K | $0.00 | |
| 2026-05-22 | ATRC | AtriCure, Inc. | S — Open-market sale | 3.0K | $28.65 | $86K |
| 2026-05-20 | ATRC | AtriCure, Inc. | A — Grant or award | 6.1K | $0.00 | |
| 2026-02-13 | EMBC | Embecta Corp. | A — Grant or award | 22.8K | $0.00 |
Prange Karen is a corporate insider — currently tracked as Director of Outset Medical, Inc. (OM). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($86K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Prange Karen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.